SCHEMBL6202972

SCHEMBL6202972

COC(O)c1cccc(OCc2ccccc2)c1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 4/20 0.59
▸ KMT2A Q03164 2/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ MEN1 O00255 1/20 0.55
▸ CYP4F2 P78329 1/20 0.53
▸ CYP4A11 Q02928 1/20 0.53
▸ BCHE P06276 2/20 0.52
▸ ALOX5 P09917 2/20 0.52
▸ LMNA P02545 1/20 0.52
▸ HPGD P15428 1/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ NR4A2 P43354 1/20 0.51
▸ SGMS2 Q8NHU3 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203969 0.84 MAOB (0.63) MAOBKMT2ASMN1; SMN2MEN1CYP4F2
SCHEMBL31748975 0.84 KMT2A (0.61) MAOBKMT2ASMN1; SMN2MEN1CYP4F2
SCHEMBL23923495 0.84 KMT2A (0.61) MAOBKMT2ASMN1; SMN2MEN1CYP4F2
SCHEMBL12221485 0.84 KMT2A (0.61) MAOBKMT2ASMN1; SMN2MEN1CYP4F2
SCHEMBL5911726 0.84 KMT2A (0.62) MAOBKMT2ASMN1; SMN2MEN1CYP4F2
SCHEMBL5772077 0.84 KMT2A (0.62) MAOBKMT2ASMN1; SMN2MEN1CYP4F2
SCHEMBL11603161 0.83 KMT2A (0.63) MAOBKMT2ASMN1; SMN2MEN1CYP4F2
SCHEMBL477599 0.83 SMN1; SMN2 (0.62) MAOBKMT2ASMN1; SMN2MEN1CYP4F2
SCHEMBL6204244 0.83 LMNA (0.58) MAOBSMN1; SMN2ALOX5LMNANR4A2
SCHEMBL20604382 0.82 KMT2A (0.62) MAOBKMT2ASMN1; SMN2MEN1CYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 — — EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 — — WO disclosed
Send feedback